Pharmafile Logo

News and Press Releases

Customised pack combines beauty and improved sustainability

Zurich, March 31, 2026 — Amcor, a global leader in developing and producing responsible packaging solutions, is supplying French hair care specialist Luxéol with a tailored version of its Prima...

Category:
Posted: March 31, 2026

Amcor
Thurgauerstrasse 34 CH-8050, Zürich, Switzerland

Levicept Announces The Lancet Publication of LEVI-04 Phase II Clinical Trial Results, Showing Significant Reduction in Pain and Symptoms of Osteoarthritis

Significant improvements in pain, function and patient global outcomes demonstrated LEVI-04 well tolerated and exhibits a favourable safety profile. 30 March 2026 -- Sandwich, UK -- Levicept Ltd, a biotechnology...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: March 30, 2026

Levicept
info@levicept.com
Innovation House Discovery Park Ramsgate Road Sandwich Kent CT13 9ND

Johnson & Johnson’s DARZALEX (daratumumab) becomes the first oncology injectable approved for administration by patients or caregivers

Landmark decision by CHMP grants approval for self or caregiver administration for patients living with multiple myeloma Milestone is a testament to ten years of daratumumab experience and innovation, continuing...

Category: Biotechnology, Clinical Trials, Drug Delivery, Drug Discovery, Pharmaceutical
Posted: March 27, 2026

Johnson & Johnson Innovative Medicine
mediaenquiries@its.jnj.com
Janssen-Cilag Limited 50-100 Holmers Farm Way High Wycombe Buckinghamshire HP12 4EG

Tozorakimab met primary endpoint in both OBERON and TITANIA Phase III trials in patients with COPD

First-ever IL-33-targeting biologic to demonstrate statistically significant and highly clinically meaningful reductions in COPD exacerbations in two replicate Phase III clinical trials 27 March 2026 -- Cambridge, UK -- Positive...

Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: March 27, 2026

AstraZeneca
Medical.InformationUK@astrazeneca.com
PLC 1 Francis Crick Avenue Cambridge Biomedical Campus Cambridge CB2 0AA UK

Lonza Launches Media Development Lab in Singapore for Cell Culture Media Optimisation

New media development services designed to optimize cell culture media development and identify robust, scalable media formulations driving cell culture performance and reliability The offering is designed to improve performance,...

Category: BioManufacturing, Biotechnology, Drug Discovery, Other, Pharmaceutical
Posted: March 26, 2026

Lonza
Muenchensteinerstrasse 38 Basel, 4002

CWOW 2026: Cambridge’s Grassroots Life Sciences Showcase Branches Out to Oxford & London

26 March 2026 -- Cambridge, UK -- Cambridge Wide Open Week (CWOW) returns 11–19 June 2026, sharing the spirit and buzz of the week-long,interactive festival with Oxford and London for...

Category: Drug Discovery, Other, Pharmaceutical
Posted: March 26, 2026

o2h
info@o2h.com
Mill SciTech Park, Mill Lane Hauxton, Cambridge CB22 5HX

ADOA PROGRAM – PRESENTATION AT NANOS 2026

PYC is a precision medicine company dedicated to changing the lives of patients with genetic diseases who have no treatment options available One of PYC’s clinical-stage programs is an investigational...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: March 24, 2026

PYC Therapeutics
info@pyctx.com
6 Verdun Street, Nedlands, Western Australia 6009

BRAIN Biotech has been granted a key patent for its CRISPR-BMC genome-editing technology

Newly patented CRISPR nuclease exhibits high activity in various prokaryotic and eukaryotic organismsPatent now opens up significant potential for further commercial use through licensing BRAIN Biotech offers its technology for...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: March 23, 2026

BRAINBiotech
public@brain-biotech.com
Darmstädter Straße 34 – 36 64673 Zwingenberg Deutschland

SLAS Announces the Cohort for Innovation AveNEW at SLAS Europe 2026

Twelve emerging life science startups to showcase enabling technologies at the SLAS European Conference and Exhibition in Vienna, 19-21 May 2026 23 March 2026 -- Vienna, Austria -- SLAS, the...

Category: Biotechnology, Drug Discovery, Other, Pharmaceutical
Posted: March 23, 2026

Society for Laboratory Automation and Screening
slas@slas.org
1301 West 22nd Street, Suite 708 Oak Brook, IL 60523 USA

Tilray Medical Announces Major Expansion of Medical Cannabis Portfolio in Australia

19 March 2026 -- New York, US and Sydney, Australia -- Tilray Medical, a recognized global leader in medical cannabis and a division of Tilray Brands, Inc. today announced its...

Category: Biotechnology, Drug Discovery, Other, Pharmaceutical
Posted: March 19, 2026

Tilray Medical
info@tilraymedical.com

BIO-Europe Spring 2026: Partnering Momentum Builds as Global Biopharma Leaders Set Course for Lisbon

16 March 2026 -- Munich, Germany -- The global biopharmaceutical community is preparing to gather in Lisbon, Portugal, for the 20th edition of BIO-Europe Spring, the premier springtime partnering conference...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: March 16, 2026

Informa
media@informa.com
5 Howick Place London SW1P 1WG UK

Samsung Biologics Recognized for Advancing Sustainability at 2026 CDMO Leadership Awards

• Reinforcing long-term commitment to embedding sustainability across operations and partnerships• Continuing to support clients in delivering high-quality, life-saving medicines to patients worldwide. 16 March 2026 -- Incheon, South Korea...

Category: BioManufacturing, Other, Pharmaceutical
Posted: March 16, 2026

Samsung Biologics
300, Songdo bio-daero, Yeonsu-gu, Incheon, Republic of Korea

BioCurie to Receive Up to $9.3 Million ARPA-H Award to Build AI Platform for Scalable Gene Therapy Manufacturing

12 March 2026 -- Delaware and Massachuetts, US -- BioCurie, a TechBio company building an AI-driven digital platform for cell and gene therapy manufacturing, was awarded up to $9.3 million...

Category: Biotechnology, Drug Delivery, Other, Pharmaceutical
Posted: March 12, 2026

BioCurie
contact@biocurie.com
112 South French Street Wilmington, Delaware 19801 USA

Kainova Therapeutics Announces Positive Phase I Results for DT-9081, an Oral EP4 Receptor Antagonist, in Advanced Solid Tumors

Phase I results demonstrate favorable safety, sustained target engagement, and early signs of anti-tumor activity Reinforce EP4 receptor antagonism as a validated, high-value strategy to overcome immunotherapy resistance. 10 March...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: March 10, 2026

Kainova Therapeutics
contact@kainovatx.com
7171 Frederick Banting Montreal, QC H4S 1Z9 Canada

University of Colorado Grants License to Cirena for RNA-Synthesis Technology

Foundational synthesis technology enables scalable modified 100-400nt RNA constructs, speeding design cycles and improving genome-editing precision 10 March 2026 -- Colorado, US -- Cirena has secured a license to the...

Category: Biotechnology, Drug Discovery, Manufacturing and Packing, Other
Posted: March 10, 2026

Cirena
rnatechsupport@cirena.com
3415 Colorado Avenue Boulder, CO 80303